Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 4/20 | 0.55 |
| ▸ | CTSS | P25774 | 4/20 | 0.55 |
| ▸ | CTSB | P07858 | 3/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
| ▸ | CTSK | P43235 | 4/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | MME | P08473 | 1/20 | 0.50 |
| ▸ | ECE1 | P42892 | 1/20 | 0.50 |
| ▸ | ELANE | P08246 | 1/20 | 0.49 |
| ▸ | CTRB1 | P17538 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6989002 | 0.89 | CTSL (0.57) | CTSLCTSSCTSBMEN1KMT2A | |
| SCHEMBL221434 | 0.86 | CTSL (0.71) | CTSLCTSSCTSBMEN1KMT2A | |
| SCHEMBL7264750 | 0.86 | CTSL (0.71) | CTSLCTSSCTSBMEN1KMT2A | |
| SCHEMBL8837344 | 0.86 | CTSL (0.71) | CTSLCTSSCTSBMEN1KMT2A | |
| SCHEMBL5145628 | 0.86 | CTSL (0.71) | CTSLCTSSCTSBMEN1KMT2A | |
| SCHEMBL24734375 | 0.86 | CTSL (0.71) | CTSLCTSSCTSBMEN1KMT2A | |
| SCHEMBL221435 | 0.86 | CTSL (0.71) | CTSLCTSSCTSBMEN1KMT2A | |
| SCHEMBL8837339 | 0.86 | CTSL (0.71) | CTSLCTSSCTSBMEN1KMT2A | |
| SCHEMBL19827398 | 0.85 | CTSL (0.56) | CTSLCTSSCTSBMEN1KMT2A | |
| SCHEMBL952348 | 0.85 | CTSL (0.58) | CTSLCTSSCTSBMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6191150-B1 | METALLOPROTEASE INHIBITOR | GLAXO WELLCOME INC. | 2001-02-20 | — | — | US | disclosed |
| WO-2000012466-A1 | FORMAMIDE COMPOUNDS AS THERAPEUTIC AGENTS | GLAXO GROUP LIMITED (GB) | 2000-03-09 | — | — | WO | disclosed |